Letro-Denk 2.5Mg Tablet 30S

• Letro-Denk 2.5mg contains letrozole an aromatase inhibitor for breast cancer • Indicated for postmenopausal women with hormone receptor positive breast cancer • Film coated Tabletlet for once daily oral administration as prescribed by an oncologist • Reduces oestrogen levels by inhibiting peripheral aromatase enzyme activity • Requires a valid prescription from a licensed physician or oncologist for dispensing • Available at Medon Pharmacy UAE

Letro-Denk 2.5mg Tabletlets contain letrozole, a third-generation aromatase inhibitor prescribed for hormone receptor-positive breast cancer in postmenopausal women. Taken once daily as directed by an oncologist, it reduces oestrogen levels to slow breast cancer growth. Benefits: • Supports hormone receptor positive breast cancer treatment with letrozole aromatase inhibition • Helps reduce oestrogen levels in postmenopausal women to slow breast cancer progression • Promotes oncological management of early and advanced breast cancer as prescribed • Relieves the hormonal drive of oestrogen-responsive breast cancer with aromatase inhibition • SuiTabletle for postmenopausal women with HR+ breast cancer as prescribed by an oncologist How to Use: • Take one Tabletlet once daily with or without food as directed by your oncologist • Swallow whole with a glass of water at the same time each day for consistency • Do not stop the medication without first consulting your oncologist or physician • Attend all scheduled oncology reviews and bone density assessments as recommended • Store in a cool dry place away from moisture heat and out of reach of children